BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19331399)

  • 1. Cellular copper import by nanocarrier systems, intracellular availability, and effects on amyloid beta peptide secretion.
    Treiber C; Quadir MA; Voigt P; Radowski M; Xu S; Munter LM; Bayer TA; Schaefer M; Haag R; Multhaup G
    Biochemistry; 2009 May; 48(20):4273-84. PubMed ID: 19331399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma.
    Mare S; Penugonda S; Robinson SM; Dohgu S; Banks WA; Ercal N
    Peptides; 2007 Jul; 28(7):1424-32. PubMed ID: 17580097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
    Kong GK; Adams JJ; Harris HH; Boas JF; Curtain CC; Galatis D; Masters CL; Barnham KJ; McKinstry WJ; Cappai R; Parker MW
    J Mol Biol; 2007 Mar; 367(1):148-61. PubMed ID: 17239395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state.
    Guilloreau L; Combalbert S; Sournia-Saquet A; Mazarguil H; Faller P
    Chembiochem; 2007 Jul; 8(11):1317-25. PubMed ID: 17577900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2008 Jul; 47(30):7796-806. PubMed ID: 18598056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
    Caragounis A; Du T; Filiz G; Laughton KM; Volitakis I; Sharples RA; Cherny RA; Masters CL; Drew SC; Hill AF; Li QX; Crouch PJ; Barnham KJ; White AR
    Biochem J; 2007 Nov; 407(3):435-50. PubMed ID: 17680773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.
    Maiti NC; Jiang D; Wain AJ; Patel S; Dinh KL; Zhou F
    J Phys Chem B; 2008 Jul; 112(28):8406-11. PubMed ID: 18570397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.
    Drew SC; Masters CL; Barnham KJ
    J Am Chem Soc; 2009 Jul; 131(25):8760-1. PubMed ID: 19496610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper transport mediated by nanocarrier systems in a blood-brain barrier in vitro model.
    Fehse S; Nowag S; Quadir M; Kim KS; Haag R; Multhaup G
    Biomacromolecules; 2014 May; 15(5):1910-9. PubMed ID: 24725062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
    Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
    Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
    Faller P; Hureau C
    Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial responses to Cu-doped TiO(2) nanoparticles.
    Wu B; Huang R; Sahu M; Feng X; Biswas P; Tang YJ
    Sci Total Environ; 2010 Mar; 408(7):1755-8. PubMed ID: 19931887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of nanoparticles to the clathrin-mediated endocytic pathway.
    Harush-Frenkel O; Debotton N; Benita S; Altschuler Y
    Biochem Biophys Res Commun; 2007 Feb; 353(1):26-32. PubMed ID: 17184736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.
    Hureau C; Faller P
    Biochimie; 2009 Oct; 91(10):1212-7. PubMed ID: 19332103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of amyloid precursor protein increases copper content in HEK293 cells.
    Suazo M; Hodar C; Morgan C; Cerpa W; Cambiazo V; Inestrosa NC; Gonzalez M
    Biochem Biophys Res Commun; 2009 May; 382(4):740-4. PubMed ID: 19318086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
    Jun S; Gillespie JR; Shin BK; Saxena S
    Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-beta1-16.
    Shin BK; Saxena S
    Biochemistry; 2008 Sep; 47(35):9117-23. PubMed ID: 18690709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+.
    Olofsson A; Lindhagen-Persson M; Vestling M; Sauer-Eriksson AE; Ohman A
    FEBS J; 2009 Aug; 276(15):4051-60. PubMed ID: 19549187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.